Lb Pharmaceuticals LBRX
NASDAQ LBRX
$36.99 -0.29 (-0.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) Non Operating Investment Income (2024 - 2025)

Updated

Lb Pharmaceuticals (LBRX) recorded Non Operating Investment Income of $119,000 in FY2025, down 87.5% from $955,000 in FY2024.

Analysis

Lb Pharmaceuticals (LBRX) Non Operating Investment Income (2024 - 2025) Analysis & Trends

  • Per Business Quant data, LBRX's Non Operating Investment Income was $955,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Lb Pharmaceuticals 1.06 Bn 1.06 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 119,000.00
Dec 31, 2024 362,000.00
Sep 30, 2024 503,000.00
API Access

Lb Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LBRX&period=max&api_key=YOUR_API_KEY